Unnatural Products Inc.

SANTA CRUZ, CA · Founded 2016 · CIK 0001788508 · Biotech · Private

Macrocyclic peptide drug platform for challenging therapeutic targets

unnaturalproducts.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$23M
2 Form D · Jul 2023
38 months since last filing
Contracts
—
No federal contracts on record
Patents
7
0 granted · 7 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,125,691
Private capital raisedForm D · SEC$17,374,312
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2353Ostentus Therapeutics, Inc.—$1.8M
2354Etheros Pharmaceuticals Corp.—$1.7M
2355DeepCyte Inc.—$1.4M
2356Unnatural Products Inc.—$23M
2357CELLULAR LOGISTICS, INC.—$1.0M
2358NEW EQUILIBRIUM BIOSCIENCES, INC.—$10M
2359Metalytics, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Vasudev BaileyDirector
  • Cameron PyeDirector · Executive Officer
  • Joshua SchwochertDirector · Executive Officer
  • Prem TumkositDirector

Patents

USPTO · 0 granted of 7
  • Cell-permeable Cyclic Peptides And Uses Thereofapplication
  • Cell-permeable Cyclic Peptides And Uses Thereofapplication
  • Cell-permeable Cyclic Peptides And Uses Thereofapplication
  • Cell-permeable Cyclic Peptides And Uses Thereofapplication
  • Cell-permeable Cyclic Peptides And Uses Thereofapplication
  • Cell-permeable Cyclic Peptides And Uses Thereofapplication
  • Cell-permeable Cyclic Peptides And Uses Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.